(Q37907415)

25 August 2017

1 reference

title

Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). (English)

1 reference

post-traumatic stress disorder

25 August 2017

main subject

0 references

0 references

2

1 reference

25 August 2017

Jonathan C Ipser

1

1 reference

25 August 2017

publication date

29 July 2011

1 reference

The International Journal of Neuropsychopharmacology

25 August 2017

published in

1 reference

25 August 2017

volume

15

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

825-840

1 reference

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

A controlled trial of phenelzine in posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Prevalence of dissociative experiences in a community sample: relationship to gender, ethnicity, and substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Assessment of a new self-rating scale for post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Current use of benzodiazepines in anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

The development of a Clinician-Administered PTSD Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Valproate in the treatment of PTSD: systematic review and meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Evaluation of the efficacy of pharmacotherapy and psychotherapy in treatment of combat-related post-traumatic stress disorder: a meta-analytic review of outcome studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Conducting Meta-Analyses in R with the metafor Package

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

Sertraline as a treatment for PTSD: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Trauma exposure and post-traumatic stress disorder in the general population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

Cognitive-affective neuroscience of depersonalization.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001209

7 January 2021

10.1017/S1461145711001209

Identifiers

DOI

1 reference

25 August 2017

1 reference